Millennium Management’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
Millennium Management's CAPR Position: Q3 2026 in Review
Millennium Management increased its Capricor Therapeutics (CAPR) stake by 614% in Q3 2026, buying an estimated $15.9M and bringing the position to 1,669,083 shares worth $15.8M. The position accounts for 0.01% of the portfolio, ranked #1838.
Millennium Management first reported a position in CAPR in Q1 2015 and has held it in 24 quarters since. The position peaked at $19.7M in Q4 2025. 155 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.
- Millennium Management held 1,669,083 shares of Capricor Therapeutics worth $15.8M as of Q3 2026.
- Millennium Management bought 1,435,157 Capricor Therapeutics shares in Q3 2026, an estimated $15.9M.
- Capricor Therapeutics made up 0.01% of Millennium Management's portfolio in Q3 2026, its #1838 holding.
- Millennium Management first reported a position in Capricor Therapeutics in Q1 2015 and has held it in 24 quarters since.
- Millennium Management's Capricor Therapeutics position peaked at $19.7M in Q4 2025.
- 155 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.